nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP3A4—bone cancer	0.578	1	CbGaD
Nicardipine—CYP2B6—Cisplatin—bone cancer	0.0226	0.255	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—bone cancer	0.0151	0.171	CbGbCtD
Nicardipine—CYP2C9—Cisplatin—bone cancer	0.0119	0.135	CbGbCtD
Nicardipine—ABCB1—Cisplatin—bone cancer	0.0116	0.131	CbGbCtD
Nicardipine—ABCB1—Doxorubicin—bone cancer	0.00777	0.0877	CbGbCtD
Nicardipine—ABCB1—Methotrexate—bone cancer	0.00752	0.085	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—bone cancer	0.00732	0.0827	CbGbCtD
Nicardipine—CYP3A4—Doxorubicin—bone cancer	0.00465	0.0526	CbGbCtD
Nicardipine—Electrocardiogram ST segment depression—Epirubicin—bone cancer	0.00356	0.0291	CcSEcCtD
Nicardipine—Electrocardiogram ST segment depression—Doxorubicin—bone cancer	0.00329	0.0269	CcSEcCtD
Nicardipine—Hypophosphataemia—Cisplatin—bone cancer	0.00271	0.0221	CcSEcCtD
Nicardipine—Pericarditis—Methotrexate—bone cancer	0.002	0.0163	CcSEcCtD
Nicardipine—Infection—Carboplatin—bone cancer	0.0019	0.0156	CcSEcCtD
Nicardipine—Pericarditis—Epirubicin—bone cancer	0.00187	0.0153	CcSEcCtD
Nicardipine—Pericarditis—Doxorubicin—bone cancer	0.00173	0.0141	CcSEcCtD
Nicardipine—Peripheral vascular disorder—Epirubicin—bone cancer	0.00165	0.0135	CcSEcCtD
Nicardipine—Pain—Carboplatin—bone cancer	0.00164	0.0134	CcSEcCtD
Nicardipine—Peripheral vascular disorder—Doxorubicin—bone cancer	0.00152	0.0125	CcSEcCtD
Nicardipine—Body temperature increased—Carboplatin—bone cancer	0.00151	0.0124	CcSEcCtD
Nicardipine—Deep vein thrombosis—Methotrexate—bone cancer	0.00142	0.0116	CcSEcCtD
Nicardipine—Hypophosphataemia—Epirubicin—bone cancer	0.00139	0.0114	CcSEcCtD
Nicardipine—Polyuria—Cisplatin—bone cancer	0.0013	0.0106	CcSEcCtD
Nicardipine—Hypophosphataemia—Doxorubicin—bone cancer	0.00129	0.0105	CcSEcCtD
Nicardipine—Lercanidipine—CYP3A4—bone cancer	0.00119	0.136	CrCbGaD
Nicardipine—Face oedema—Cisplatin—bone cancer	0.0011	0.00902	CcSEcCtD
Nicardipine—Isradipine—CYP3A4—bone cancer	0.00108	0.123	CrCbGaD
Nicardipine—Orthostatic hypotension—Cisplatin—bone cancer	0.00104	0.00853	CcSEcCtD
Nicardipine—Hypokalaemia—Cisplatin—bone cancer	0.00104	0.0085	CcSEcCtD
Nicardipine—Injection site pain—Epirubicin—bone cancer	0.000989	0.0081	CcSEcCtD
Nicardipine—Sweating increased—Cisplatin—bone cancer	0.000961	0.00787	CcSEcCtD
Nicardipine—Clevidipine—CYP3A4—bone cancer	0.000948	0.108	CrCbGaD
Nicardipine—Vasodilation—Epirubicin—bone cancer	0.000919	0.00752	CcSEcCtD
Nicardipine—Vasodilation procedure—Epirubicin—bone cancer	0.000919	0.00752	CcSEcCtD
Nicardipine—Injection site pain—Doxorubicin—bone cancer	0.000915	0.00749	CcSEcCtD
Nicardipine—Nisoldipine—CYP3A4—bone cancer	0.000909	0.104	CrCbGaD
Nicardipine—Ventricular extrasystoles—Epirubicin—bone cancer	0.000894	0.00732	CcSEcCtD
Nicardipine—Nimodipine—CYP3A4—bone cancer	0.000878	0.1	CrCbGaD
Nicardipine—Nocturia—Epirubicin—bone cancer	0.000871	0.00713	CcSEcCtD
Nicardipine—Acute coronary syndrome—Cisplatin—bone cancer	0.000867	0.0071	CcSEcCtD
Nicardipine—Myocardial infarction—Cisplatin—bone cancer	0.000863	0.00706	CcSEcCtD
Nicardipine—Conjunctivitis—Cisplatin—bone cancer	0.000855	0.007	CcSEcCtD
Nicardipine—Vasodilation procedure—Doxorubicin—bone cancer	0.000851	0.00696	CcSEcCtD
Nicardipine—Vasodilation—Doxorubicin—bone cancer	0.000851	0.00696	CcSEcCtD
Nicardipine—Nilvadipine—CYP3A4—bone cancer	0.00085	0.097	CrCbGaD
Nicardipine—Nitrendipine—CYP3A4—bone cancer	0.00085	0.097	CrCbGaD
Nicardipine—Atrioventricular block—Epirubicin—bone cancer	0.000833	0.00681	CcSEcCtD
Nicardipine—Ventricular extrasystoles—Doxorubicin—bone cancer	0.000828	0.00677	CcSEcCtD
Nicardipine—Neck pain—Epirubicin—bone cancer	0.000818	0.00669	CcSEcCtD
Nicardipine—Ventricular tachycardia—Epirubicin—bone cancer	0.000808	0.00661	CcSEcCtD
Nicardipine—Nocturia—Doxorubicin—bone cancer	0.000806	0.00659	CcSEcCtD
Nicardipine—Injection site reaction—Epirubicin—bone cancer	0.000803	0.00657	CcSEcCtD
Nicardipine—Abnormal dreams—Epirubicin—bone cancer	0.000798	0.00653	CcSEcCtD
Nicardipine—Urine output increased—Methotrexate—bone cancer	0.00078	0.00639	CcSEcCtD
Nicardipine—Atrioventricular block—Doxorubicin—bone cancer	0.000771	0.00631	CcSEcCtD
Nicardipine—Visual impairment—Cisplatin—bone cancer	0.000761	0.00623	CcSEcCtD
Nicardipine—Neck pain—Doxorubicin—bone cancer	0.000757	0.00619	CcSEcCtD
Nicardipine—Ventricular tachycardia—Doxorubicin—bone cancer	0.000747	0.00612	CcSEcCtD
Nicardipine—Injection site reaction—Doxorubicin—bone cancer	0.000743	0.00608	CcSEcCtD
Nicardipine—Abnormal dreams—Doxorubicin—bone cancer	0.000739	0.00604	CcSEcCtD
Nicardipine—Tinnitus—Cisplatin—bone cancer	0.000736	0.00603	CcSEcCtD
Nicardipine—Flushing—Cisplatin—bone cancer	0.000733	0.006	CcSEcCtD
Nicardipine—Amlodipine—CYP3A4—bone cancer	0.000732	0.0835	CrCbGaD
Nicardipine—Polyuria—Methotrexate—bone cancer	0.000714	0.00584	CcSEcCtD
Nicardipine—Hypertonia—Epirubicin—bone cancer	0.000708	0.00579	CcSEcCtD
Nicardipine—Abnormal vision—Epirubicin—bone cancer	0.000705	0.00577	CcSEcCtD
Nicardipine—Felodipine—CYP3A4—bone cancer	0.000677	0.0772	CrCbGaD
Nicardipine—Hypertonia—Doxorubicin—bone cancer	0.000655	0.00536	CcSEcCtD
Nicardipine—Nifedipine—CYP3A4—bone cancer	0.000655	0.0747	CrCbGaD
Nicardipine—Abnormal vision—Doxorubicin—bone cancer	0.000652	0.00533	CcSEcCtD
Nicardipine—Vision blurred—Cisplatin—bone cancer	0.000648	0.0053	CcSEcCtD
Nicardipine—Tremor—Cisplatin—bone cancer	0.000644	0.00527	CcSEcCtD
Nicardipine—Ill-defined disorder—Cisplatin—bone cancer	0.000638	0.00522	CcSEcCtD
Nicardipine—Hot flush—Epirubicin—bone cancer	0.000627	0.00513	CcSEcCtD
Nicardipine—Menopausal symptoms—Epirubicin—bone cancer	0.000621	0.00509	CcSEcCtD
Nicardipine—Malaise—Cisplatin—bone cancer	0.00062	0.00507	CcSEcCtD
Nicardipine—Myalgia—Cisplatin—bone cancer	0.000585	0.00479	CcSEcCtD
Nicardipine—Anxiety—Cisplatin—bone cancer	0.000583	0.00477	CcSEcCtD
Nicardipine—Hot flush—Doxorubicin—bone cancer	0.00058	0.00475	CcSEcCtD
Nicardipine—Discomfort—Cisplatin—bone cancer	0.000578	0.00473	CcSEcCtD
Nicardipine—Menopausal symptoms—Doxorubicin—bone cancer	0.000575	0.00471	CcSEcCtD
Nicardipine—Face oedema—Epirubicin—bone cancer	0.000566	0.00463	CcSEcCtD
Nicardipine—Oedema—Cisplatin—bone cancer	0.000561	0.00459	CcSEcCtD
Nicardipine—Infection—Cisplatin—bone cancer	0.000558	0.00456	CcSEcCtD
Nicardipine—Thrombocytopenia—Cisplatin—bone cancer	0.000549	0.0045	CcSEcCtD
Nicardipine—Tachycardia—Cisplatin—bone cancer	0.000548	0.00448	CcSEcCtD
Nicardipine—Hyperhidrosis—Cisplatin—bone cancer	0.000543	0.00444	CcSEcCtD
Nicardipine—Orthostatic hypotension—Epirubicin—bone cancer	0.000536	0.00438	CcSEcCtD
Nicardipine—Hypokalaemia—Epirubicin—bone cancer	0.000534	0.00437	CcSEcCtD
Nicardipine—Hypotension—Cisplatin—bone cancer	0.000524	0.00429	CcSEcCtD
Nicardipine—Face oedema—Doxorubicin—bone cancer	0.000524	0.00429	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000511	0.00418	CcSEcCtD
Nicardipine—Paraesthesia—Cisplatin—bone cancer	0.000504	0.00412	CcSEcCtD
Nicardipine—Dyspnoea—Cisplatin—bone cancer	0.0005	0.00409	CcSEcCtD
Nicardipine—Erectile dysfunction—Methotrexate—bone cancer	0.000499	0.00408	CcSEcCtD
Nicardipine—Orthostatic hypotension—Doxorubicin—bone cancer	0.000496	0.00406	CcSEcCtD
Nicardipine—Hypokalaemia—Doxorubicin—bone cancer	0.000494	0.00404	CcSEcCtD
Nicardipine—Angina pectoris—Epirubicin—bone cancer	0.000494	0.00404	CcSEcCtD
Nicardipine—Pain—Cisplatin—bone cancer	0.00048	0.00393	CcSEcCtD
Nicardipine—Conjunctivitis—Methotrexate—bone cancer	0.000469	0.00384	CcSEcCtD
Nicardipine—Pollakiuria—Epirubicin—bone cancer	0.000468	0.00383	CcSEcCtD
Nicardipine—Sweating—Methotrexate—bone cancer	0.000463	0.00379	CcSEcCtD
Nicardipine—Feeling abnormal—Cisplatin—bone cancer	0.000462	0.00378	CcSEcCtD
Nicardipine—Haematuria—Methotrexate—bone cancer	0.00046	0.00377	CcSEcCtD
Nicardipine—Angina pectoris—Doxorubicin—bone cancer	0.000457	0.00374	CcSEcCtD
Nicardipine—Body temperature increased—Cisplatin—bone cancer	0.000444	0.00363	CcSEcCtD
Nicardipine—Conjunctivitis—Epirubicin—bone cancer	0.000439	0.00359	CcSEcCtD
Nicardipine—Sweating—Epirubicin—bone cancer	0.000433	0.00355	CcSEcCtD
Nicardipine—Pollakiuria—Doxorubicin—bone cancer	0.000433	0.00354	CcSEcCtD
Nicardipine—Haematuria—Epirubicin—bone cancer	0.000431	0.00353	CcSEcCtD
Nicardipine—Sinusitis—Epirubicin—bone cancer	0.000424	0.00347	CcSEcCtD
Nicardipine—Visual impairment—Methotrexate—bone cancer	0.000418	0.00342	CcSEcCtD
Nicardipine—Hypersensitivity—Cisplatin—bone cancer	0.000413	0.00338	CcSEcCtD
Nicardipine—Rhinitis—Epirubicin—bone cancer	0.000407	0.00333	CcSEcCtD
Nicardipine—Conjunctivitis—Doxorubicin—bone cancer	0.000406	0.00333	CcSEcCtD
Nicardipine—Tinnitus—Methotrexate—bone cancer	0.000404	0.00331	CcSEcCtD
Nicardipine—Hypoaesthesia—Epirubicin—bone cancer	0.000404	0.0033	CcSEcCtD
Nicardipine—Asthenia—Cisplatin—bone cancer	0.000403	0.00329	CcSEcCtD
Nicardipine—Sweating—Doxorubicin—bone cancer	0.000401	0.00328	CcSEcCtD
Nicardipine—Oedema peripheral—Epirubicin—bone cancer	0.0004	0.00327	CcSEcCtD
Nicardipine—Haematuria—Doxorubicin—bone cancer	0.000399	0.00326	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—bone cancer	0.000392	0.00321	CcSEcCtD
Nicardipine—Visual impairment—Epirubicin—bone cancer	0.000391	0.0032	CcSEcCtD
Nicardipine—Diarrhoea—Cisplatin—bone cancer	0.000384	0.00314	CcSEcCtD
Nicardipine—Tinnitus—Epirubicin—bone cancer	0.000378	0.0031	CcSEcCtD
Nicardipine—Flushing—Epirubicin—bone cancer	0.000376	0.00308	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—bone cancer	0.000376	0.00308	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—bone cancer	0.000373	0.00306	CcSEcCtD
Nicardipine—Oedema peripheral—Doxorubicin—bone cancer	0.00037	0.00303	CcSEcCtD
Nicardipine—Visual impairment—Doxorubicin—bone cancer	0.000362	0.00296	CcSEcCtD
Nicardipine—Vomiting—Cisplatin—bone cancer	0.000357	0.00292	CcSEcCtD
Nicardipine—Vision blurred—Methotrexate—bone cancer	0.000356	0.00291	CcSEcCtD
Nicardipine—Rash—Cisplatin—bone cancer	0.000354	0.0029	CcSEcCtD
Nicardipine—Dermatitis—Cisplatin—bone cancer	0.000354	0.00289	CcSEcCtD
Nicardipine—Ill-defined disorder—Methotrexate—bone cancer	0.00035	0.00287	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—bone cancer	0.00035	0.00286	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—bone cancer	0.000348	0.00285	CcSEcCtD
Nicardipine—Tension—Epirubicin—bone cancer	0.000347	0.00284	CcSEcCtD
Nicardipine—Nervousness—Epirubicin—bone cancer	0.000343	0.00281	CcSEcCtD
Nicardipine—Malaise—Methotrexate—bone cancer	0.00034	0.00278	CcSEcCtD
Nicardipine—Vertigo—Methotrexate—bone cancer	0.000339	0.00277	CcSEcCtD
Nicardipine—Nausea—Cisplatin—bone cancer	0.000333	0.00273	CcSEcCtD
Nicardipine—Vision blurred—Epirubicin—bone cancer	0.000333	0.00272	CcSEcCtD
Nicardipine—Ill-defined disorder—Epirubicin—bone cancer	0.000328	0.00268	CcSEcCtD
Nicardipine—Agitation—Epirubicin—bone cancer	0.000325	0.00266	CcSEcCtD
Nicardipine—Myalgia—Methotrexate—bone cancer	0.000321	0.00263	CcSEcCtD
Nicardipine—Chest pain—Methotrexate—bone cancer	0.000321	0.00263	CcSEcCtD
Nicardipine—Arthralgia—Methotrexate—bone cancer	0.000321	0.00263	CcSEcCtD
Nicardipine—Tension—Doxorubicin—bone cancer	0.000321	0.00262	CcSEcCtD
Nicardipine—Malaise—Epirubicin—bone cancer	0.000318	0.00261	CcSEcCtD
Nicardipine—Discomfort—Methotrexate—bone cancer	0.000317	0.0026	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—bone cancer	0.000317	0.0026	CcSEcCtD
Nicardipine—Vertigo—Epirubicin—bone cancer	0.000317	0.0026	CcSEcCtD
Nicardipine—Syncope—Epirubicin—bone cancer	0.000317	0.00259	CcSEcCtD
Nicardipine—Palpitations—Epirubicin—bone cancer	0.000312	0.00255	CcSEcCtD
Nicardipine—Confusional state—Methotrexate—bone cancer	0.000311	0.00254	CcSEcCtD
Nicardipine—Loss of consciousness—Epirubicin—bone cancer	0.00031	0.00254	CcSEcCtD
Nicardipine—Vision blurred—Doxorubicin—bone cancer	0.000308	0.00252	CcSEcCtD
Nicardipine—Infection—Methotrexate—bone cancer	0.000306	0.0025	CcSEcCtD
Nicardipine—Hypertension—Epirubicin—bone cancer	0.000305	0.00249	CcSEcCtD
Nicardipine—Ill-defined disorder—Doxorubicin—bone cancer	0.000303	0.00248	CcSEcCtD
Nicardipine—Thrombocytopenia—Methotrexate—bone cancer	0.000302	0.00247	CcSEcCtD
Nicardipine—Chest pain—Epirubicin—bone cancer	0.000301	0.00246	CcSEcCtD
Nicardipine—Myalgia—Epirubicin—bone cancer	0.000301	0.00246	CcSEcCtD
Nicardipine—Arthralgia—Epirubicin—bone cancer	0.000301	0.00246	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—bone cancer	0.0003	0.00246	CcSEcCtD
Nicardipine—Anxiety—Epirubicin—bone cancer	0.0003	0.00245	CcSEcCtD
Nicardipine—Hyperhidrosis—Methotrexate—bone cancer	0.000298	0.00244	CcSEcCtD
Nicardipine—Discomfort—Epirubicin—bone cancer	0.000297	0.00243	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—bone cancer	0.000295	0.00241	CcSEcCtD
Nicardipine—Dry mouth—Epirubicin—bone cancer	0.000294	0.00241	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—bone cancer	0.000294	0.0024	CcSEcCtD
Nicardipine—Syncope—Doxorubicin—bone cancer	0.000293	0.0024	CcSEcCtD
Nicardipine—Confusional state—Epirubicin—bone cancer	0.000291	0.00238	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—bone cancer	0.000289	0.00236	CcSEcCtD
Nicardipine—Oedema—Epirubicin—bone cancer	0.000288	0.00236	CcSEcCtD
Nicardipine—Hypotension—Methotrexate—bone cancer	0.000288	0.00235	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—bone cancer	0.000287	0.00235	CcSEcCtD
Nicardipine—Infection—Epirubicin—bone cancer	0.000286	0.00234	CcSEcCtD
Nicardipine—Shock—Epirubicin—bone cancer	0.000284	0.00232	CcSEcCtD
Nicardipine—Thrombocytopenia—Epirubicin—bone cancer	0.000282	0.00231	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—bone cancer	0.000282	0.00231	CcSEcCtD
Nicardipine—Tachycardia—Epirubicin—bone cancer	0.000281	0.0023	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000281	0.0023	CcSEcCtD
Nicardipine—Hyperhidrosis—Epirubicin—bone cancer	0.000279	0.00228	CcSEcCtD
Nicardipine—Insomnia—Methotrexate—bone cancer	0.000279	0.00228	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—bone cancer	0.000278	0.00228	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—bone cancer	0.000278	0.00228	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—bone cancer	0.000278	0.00228	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—bone cancer	0.000277	0.00227	CcSEcCtD
Nicardipine—Paraesthesia—Methotrexate—bone cancer	0.000277	0.00226	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—bone cancer	0.000275	0.00225	CcSEcCtD
Nicardipine—Dyspnoea—Methotrexate—bone cancer	0.000275	0.00225	CcSEcCtD
Nicardipine—Somnolence—Methotrexate—bone cancer	0.000274	0.00224	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—bone cancer	0.000272	0.00223	CcSEcCtD
Nicardipine—Dyspepsia—Methotrexate—bone cancer	0.000271	0.00222	CcSEcCtD
Nicardipine—Hypotension—Epirubicin—bone cancer	0.000269	0.0022	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—bone cancer	0.000269	0.0022	CcSEcCtD
Nicardipine—Oedema—Doxorubicin—bone cancer	0.000267	0.00218	CcSEcCtD
Nicardipine—Infection—Doxorubicin—bone cancer	0.000265	0.00217	CcSEcCtD
Nicardipine—Pain—Methotrexate—bone cancer	0.000263	0.00216	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000263	0.00215	CcSEcCtD
Nicardipine—Shock—Doxorubicin—bone cancer	0.000262	0.00215	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—bone cancer	0.000261	0.00214	CcSEcCtD
Nicardipine—Insomnia—Epirubicin—bone cancer	0.000261	0.00213	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—bone cancer	0.00026	0.00213	CcSEcCtD
Nicardipine—Paraesthesia—Epirubicin—bone cancer	0.000259	0.00212	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—bone cancer	0.000258	0.00211	CcSEcCtD
Nicardipine—Dyspnoea—Epirubicin—bone cancer	0.000257	0.0021	CcSEcCtD
Nicardipine—Somnolence—Epirubicin—bone cancer	0.000256	0.0021	CcSEcCtD
Nicardipine—Feeling abnormal—Methotrexate—bone cancer	0.000254	0.00208	CcSEcCtD
Nicardipine—Dyspepsia—Epirubicin—bone cancer	0.000254	0.00208	CcSEcCtD
Nicardipine—Gastrointestinal pain—Methotrexate—bone cancer	0.000252	0.00206	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—bone cancer	0.000249	0.00204	CcSEcCtD
Nicardipine—Constipation—Epirubicin—bone cancer	0.000246	0.00202	CcSEcCtD
Nicardipine—Pain—Epirubicin—bone cancer	0.000246	0.00202	CcSEcCtD
Nicardipine—Abdominal pain—Methotrexate—bone cancer	0.000243	0.00199	CcSEcCtD
Nicardipine—Body temperature increased—Methotrexate—bone cancer	0.000243	0.00199	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000243	0.00199	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—bone cancer	0.000241	0.00197	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—bone cancer	0.000239	0.00196	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—bone cancer	0.000238	0.00195	CcSEcCtD
Nicardipine—Feeling abnormal—Epirubicin—bone cancer	0.000237	0.00194	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—bone cancer	0.000237	0.00194	CcSEcCtD
Nicardipine—Gastrointestinal pain—Epirubicin—bone cancer	0.000236	0.00193	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—bone cancer	0.000235	0.00192	CcSEcCtD
Nicardipine—Pain—Doxorubicin—bone cancer	0.000228	0.00187	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—bone cancer	0.000228	0.00187	CcSEcCtD
Nicardipine—Body temperature increased—Epirubicin—bone cancer	0.000228	0.00186	CcSEcCtD
Nicardipine—Abdominal pain—Epirubicin—bone cancer	0.000228	0.00186	CcSEcCtD
Nicardipine—Hypersensitivity—Methotrexate—bone cancer	0.000227	0.00186	CcSEcCtD
Nicardipine—Asthenia—Methotrexate—bone cancer	0.000221	0.00181	CcSEcCtD
Nicardipine—Feeling abnormal—Doxorubicin—bone cancer	0.00022	0.0018	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000218	0.00178	CcSEcCtD
Nicardipine—Hypersensitivity—Epirubicin—bone cancer	0.000212	0.00174	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—bone cancer	0.000211	0.00173	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—bone cancer	0.000211	0.00173	CcSEcCtD
Nicardipine—Diarrhoea—Methotrexate—bone cancer	0.000211	0.00172	CcSEcCtD
Nicardipine—Asthenia—Epirubicin—bone cancer	0.000207	0.00169	CcSEcCtD
Nicardipine—Dizziness—Methotrexate—bone cancer	0.000204	0.00167	CcSEcCtD
Nicardipine—Diarrhoea—Epirubicin—bone cancer	0.000197	0.00161	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—bone cancer	0.000196	0.00161	CcSEcCtD
Nicardipine—Vomiting—Methotrexate—bone cancer	0.000196	0.0016	CcSEcCtD
Nicardipine—Rash—Methotrexate—bone cancer	0.000194	0.00159	CcSEcCtD
Nicardipine—Dermatitis—Methotrexate—bone cancer	0.000194	0.00159	CcSEcCtD
Nicardipine—Headache—Methotrexate—bone cancer	0.000193	0.00158	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—bone cancer	0.000191	0.00157	CcSEcCtD
Nicardipine—Dizziness—Epirubicin—bone cancer	0.000191	0.00156	CcSEcCtD
Nicardipine—Vomiting—Epirubicin—bone cancer	0.000183	0.0015	CcSEcCtD
Nicardipine—Nausea—Methotrexate—bone cancer	0.000183	0.0015	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—bone cancer	0.000182	0.00149	CcSEcCtD
Nicardipine—Rash—Epirubicin—bone cancer	0.000182	0.00149	CcSEcCtD
Nicardipine—Dermatitis—Epirubicin—bone cancer	0.000182	0.00149	CcSEcCtD
Nicardipine—Headache—Epirubicin—bone cancer	0.000181	0.00148	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—bone cancer	0.000176	0.00144	CcSEcCtD
Nicardipine—Nausea—Epirubicin—bone cancer	0.000171	0.0014	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—bone cancer	0.00017	0.00139	CcSEcCtD
Nicardipine—Rash—Doxorubicin—bone cancer	0.000168	0.00138	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—bone cancer	0.000168	0.00137	CcSEcCtD
Nicardipine—Headache—Doxorubicin—bone cancer	0.000167	0.00137	CcSEcCtD
Nicardipine—Nausea—Doxorubicin—bone cancer	0.000158	0.0013	CcSEcCtD
Nicardipine—CHRM3—Signaling Pathways—GNA11—bone cancer	2.95e-05	0.000146	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—GNA11—bone cancer	2.92e-05	0.000144	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—GNA11—bone cancer	2.92e-05	0.000144	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IGF1R—bone cancer	2.89e-05	0.000143	CbGpPWpGaD
Nicardipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.88e-05	0.000142	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—GNA11—bone cancer	2.86e-05	0.000141	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—GNA11—bone cancer	2.86e-05	0.000141	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—MDM2—bone cancer	2.84e-05	0.00014	CbGpPWpGaD
Nicardipine—PDE1A—Disease—EGFR—bone cancer	2.77e-05	0.000137	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—CYP3A4—bone cancer	2.75e-05	0.000136	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—ATF1—bone cancer	2.75e-05	0.000136	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—DHFR—bone cancer	2.75e-05	0.000136	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—EGFR—bone cancer	2.75e-05	0.000136	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—ATF1—bone cancer	2.75e-05	0.000136	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—GSTP1—bone cancer	2.74e-05	0.000135	CbGpPWpGaD
Nicardipine—CALM3—Disease—TGFBR2—bone cancer	2.74e-05	0.000135	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—MDM2—bone cancer	2.74e-05	0.000135	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—ATF1—bone cancer	2.72e-05	0.000134	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—ATF1—bone cancer	2.71e-05	0.000134	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SMO—bone cancer	2.7e-05	0.000134	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—CYP3A4—bone cancer	2.7e-05	0.000133	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—PTGS2—bone cancer	2.7e-05	0.000133	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—CYP3A4—bone cancer	2.69e-05	0.000133	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL3—bone cancer	2.69e-05	0.000133	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—CYP3A4—bone cancer	2.68e-05	0.000132	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL3—bone cancer	2.68e-05	0.000132	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL3—bone cancer	2.65e-05	0.000131	CbGpPWpGaD
Nicardipine—CALM2—Disease—TGFBR2—bone cancer	2.65e-05	0.000131	CbGpPWpGaD
Nicardipine—CALM1—Disease—TGFBR2—bone cancer	2.65e-05	0.000131	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—ENO2—bone cancer	2.65e-05	0.000131	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—MDM2—bone cancer	2.65e-05	0.000131	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—MDM2—bone cancer	2.65e-05	0.000131	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL3—bone cancer	2.64e-05	0.000131	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—MDM2—bone cancer	2.63e-05	0.00013	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SMO—bone cancer	2.62e-05	0.000129	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SMO—bone cancer	2.62e-05	0.000129	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—MDM2—bone cancer	2.6e-05	0.000128	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—CYP3A4—bone cancer	2.59e-05	0.000128	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—CYP3A4—bone cancer	2.59e-05	0.000128	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—ENO2—bone cancer	2.58e-05	0.000128	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—GNA11—bone cancer	2.57e-05	0.000127	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	2.55e-05	0.000126	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—MDM2—bone cancer	2.54e-05	0.000126	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—MDM2—bone cancer	2.54e-05	0.000126	CbGpPWpGaD
Nicardipine—PDE1B—Disease—EGFR—bone cancer	2.54e-05	0.000125	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—GNA11—bone cancer	2.47e-05	0.000122	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—JUN—bone cancer	2.47e-05	0.000122	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—DHFR—bone cancer	2.46e-05	0.000121	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ENO2—bone cancer	2.44e-05	0.00012	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ENO2—bone cancer	2.41e-05	0.000119	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—MMP9—bone cancer	2.4e-05	0.000119	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—DHFR—bone cancer	2.4e-05	0.000118	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IGF1R—bone cancer	2.4e-05	0.000118	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—GNA11—bone cancer	2.39e-05	0.000118	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—GNA11—bone cancer	2.39e-05	0.000118	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—JUN—bone cancer	2.38e-05	0.000117	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—GSTP1—bone cancer	2.36e-05	0.000116	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—CYP3A4—bone cancer	2.33e-05	0.000115	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—KIT—bone cancer	2.32e-05	0.000115	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.32e-05	0.000115	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—GSTP1—bone cancer	2.31e-05	0.000114	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—GSTP1—bone cancer	2.3e-05	0.000114	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—JUN—bone cancer	2.3e-05	0.000114	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—JUN—bone cancer	2.3e-05	0.000114	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—ATF1—bone cancer	2.3e-05	0.000114	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFBR2—bone cancer	2.3e-05	0.000113	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—GNA11—bone cancer	2.3e-05	0.000113	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—GSTP1—bone cancer	2.29e-05	0.000113	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFBR2—bone cancer	2.29e-05	0.000113	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFBR2—bone cancer	2.27e-05	0.000112	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	2.26e-05	0.000112	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—DHFR—bone cancer	2.26e-05	0.000112	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—JUN—bone cancer	2.26e-05	0.000112	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL3—bone cancer	2.24e-05	0.000111	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—GNA11—bone cancer	2.24e-05	0.000111	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—DHFR—bone cancer	2.24e-05	0.000111	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—KIT—bone cancer	2.23e-05	0.00011	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ATF1—bone cancer	2.22e-05	0.00011	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ATF1—bone cancer	2.22e-05	0.00011	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—GSTP1—bone cancer	2.22e-05	0.00011	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—GSTP1—bone cancer	2.22e-05	0.00011	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—MMP9—bone cancer	2.2e-05	0.000109	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—BRAF—bone cancer	2.19e-05	0.000108	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL3—bone cancer	2.17e-05	0.000107	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL3—bone cancer	2.17e-05	0.000107	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IGF1R—bone cancer	2.16e-05	0.000107	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IGF1R—bone cancer	2.15e-05	0.000106	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IGF1R—bone cancer	2.13e-05	0.000105	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	2.13e-05	0.000105	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—EGFR—bone cancer	2.12e-05	0.000105	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—GNA11—bone cancer	2.11e-05	0.000104	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—GNA11—bone cancer	2.09e-05	0.000103	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—KIT—bone cancer	2.09e-05	0.000103	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—BRAF—bone cancer	2.09e-05	0.000103	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—CYP3A4—bone cancer	2.08e-05	0.000103	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.07e-05	0.000102	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—CYP3A4—bone cancer	2.03e-05	0.0001	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—EGFR—bone cancer	2.03e-05	0.0001	CbGpPWpGaD
Nicardipine—CALM3—Immune System—KIT—bone cancer	2.02e-05	9.99e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—GSTP1—bone cancer	1.99e-05	9.85e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—BRAF—bone cancer	1.97e-05	9.72e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KIT—bone cancer	1.96e-05	9.67e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KIT—bone cancer	1.96e-05	9.67e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—EGFR—bone cancer	1.94e-05	9.59e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFBR2—bone cancer	1.92e-05	9.47e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.91e-05	9.45e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—EGFR—bone cancer	1.91e-05	9.42e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—CYP3A4—bone cancer	1.9e-05	9.37e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.89e-05	9.33e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—EGFR—bone cancer	1.87e-05	9.23e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—KIT—bone cancer	1.87e-05	9.23e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFBR2—bone cancer	1.85e-05	9.16e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFBR2—bone cancer	1.85e-05	9.16e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MDM2—bone cancer	1.83e-05	9.04e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—EGFR—bone cancer	1.81e-05	8.93e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—EGFR—bone cancer	1.81e-05	8.93e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—KIT—bone cancer	1.81e-05	8.92e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—KIT—bone cancer	1.81e-05	8.92e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IGF1R—bone cancer	1.8e-05	8.91e-05	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—EGFR—bone cancer	1.8e-05	8.87e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—GSTP1—bone cancer	1.78e-05	8.79e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—EGFR—bone cancer	1.78e-05	8.77e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—BRAF—bone cancer	1.76e-05	8.67e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MDM2—bone cancer	1.75e-05	8.66e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IGF1R—bone cancer	1.74e-05	8.62e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IGF1R—bone cancer	1.74e-05	8.62e-05	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—TP53—bone cancer	1.74e-05	8.61e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—GSTP1—bone cancer	1.74e-05	8.58e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KIT—bone cancer	1.74e-05	8.58e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—EGFR—bone cancer	1.74e-05	8.58e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—EGFR—bone cancer	1.74e-05	8.58e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—BRAF—bone cancer	1.7e-05	8.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—BRAF—bone cancer	1.7e-05	8.39e-05	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—TP53—bone cancer	1.69e-05	8.33e-05	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—TP53—bone cancer	1.69e-05	8.33e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MDM2—bone cancer	1.65e-05	8.14e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—GSTP1—bone cancer	1.64e-05	8.09e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.63e-05	8.06e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—TP53—bone cancer	1.63e-05	8.05e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—GSTP1—bone cancer	1.62e-05	8.02e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—MDM2—bone cancer	1.59e-05	7.87e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ENO2—bone cancer	1.59e-05	7.86e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—JUN—bone cancer	1.59e-05	7.86e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.58e-05	7.82e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KIT—bone cancer	1.57e-05	7.74e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KIT—bone cancer	1.56e-05	7.72e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MMP9—bone cancer	1.55e-05	7.65e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KIT—bone cancer	1.55e-05	7.64e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KIT—bone cancer	1.54e-05	7.62e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—MDM2—bone cancer	1.54e-05	7.61e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—MDM2—bone cancer	1.54e-05	7.61e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—JUN—bone cancer	1.52e-05	7.53e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—TP53—bone cancer	1.49e-05	7.36e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MMP9—bone cancer	1.48e-05	7.32e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—DHFR—bone cancer	1.48e-05	7.3e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—BRAF—bone cancer	1.47e-05	7.28e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MDM2—bone cancer	1.47e-05	7.27e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—BRAF—bone cancer	1.47e-05	7.25e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—BRAF—bone cancer	1.45e-05	7.18e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.45e-05	7.16e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—JUN—bone cancer	1.43e-05	7.08e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—EGFR—bone cancer	1.43e-05	7.05e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—EGFR—bone cancer	1.42e-05	7.03e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MDM2—bone cancer	1.42e-05	7.03e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MDM2—bone cancer	1.42e-05	7.03e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PTGS2—bone cancer	1.42e-05	7.01e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PTGS2—bone cancer	1.42e-05	7e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—EGFR—bone cancer	1.41e-05	6.96e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.41e-05	6.94e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MMP9—bone cancer	1.39e-05	6.88e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—JUN—bone cancer	1.39e-05	6.84e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GNA11—bone cancer	1.38e-05	6.82e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PTGS2—bone cancer	1.37e-05	6.78e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PTGS2—bone cancer	1.37e-05	6.78e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MDM2—bone cancer	1.37e-05	6.76e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—JUN—bone cancer	1.34e-05	6.62e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—JUN—bone cancer	1.34e-05	6.62e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KIT—bone cancer	1.31e-05	6.46e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KIT—bone cancer	1.27e-05	6.25e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KIT—bone cancer	1.27e-05	6.25e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—EGFR—bone cancer	1.25e-05	6.18e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MDM2—bone cancer	1.23e-05	6.1e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MDM2—bone cancer	1.23e-05	6.08e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—BRAF—bone cancer	1.23e-05	6.07e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTGS2—bone cancer	1.22e-05	6.03e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MDM2—bone cancer	1.22e-05	6.02e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MDM2—bone cancer	1.22e-05	6e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—EGFR—bone cancer	1.2e-05	5.92e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTGS2—bone cancer	1.2e-05	5.9e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTGS2—bone cancer	1.19e-05	5.89e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—EGFR—bone cancer	1.19e-05	5.89e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—BRAF—bone cancer	1.19e-05	5.87e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—BRAF—bone cancer	1.19e-05	5.87e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—JUN—bone cancer	1.19e-05	5.87e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTGS2—bone cancer	1.19e-05	5.87e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MMP9—bone cancer	1.16e-05	5.71e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—EGFR—bone cancer	1.15e-05	5.69e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—EGFR—bone cancer	1.15e-05	5.69e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTGS2—bone cancer	1.15e-05	5.67e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTGS2—bone cancer	1.15e-05	5.67e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—EGFR—bone cancer	1.13e-05	5.56e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—EGFR—bone cancer	1.09e-05	5.38e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—JUN—bone cancer	1.07e-05	5.3e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GSTP1—bone cancer	1.07e-05	5.29e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—JUN—bone cancer	1.07e-05	5.28e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—JUN—bone cancer	1.06e-05	5.23e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—JUN—bone cancer	1.06e-05	5.22e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EGFR—bone cancer	1.05e-05	5.2e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EGFR—bone cancer	1.05e-05	5.2e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—bone cancer	1.05e-05	5.19e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MMP9—bone cancer	1.04e-05	5.16e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MMP9—bone cancer	1.04e-05	5.14e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTGS2—bone cancer	1.03e-05	5.1e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MMP9—bone cancer	1.03e-05	5.09e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MDM2—bone cancer	1.03e-05	5.09e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MMP9—bone cancer	1.03e-05	5.08e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—bone cancer	1.01e-05	4.97e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—bone cancer	1.01e-05	4.97e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MDM2—bone cancer	9.97e-06	4.92e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MDM2—bone cancer	9.97e-06	4.92e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—bone cancer	9.73e-06	4.8e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—bone cancer	9.73e-06	4.8e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—bone cancer	9.46e-06	4.67e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—bone cancer	9.35e-06	4.62e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—bone cancer	9.22e-06	4.55e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—bone cancer	9e-06	4.45e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—JUN—bone cancer	8.96e-06	4.42e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—bone cancer	8.71e-06	4.3e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—JUN—bone cancer	8.66e-06	4.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—JUN—bone cancer	8.66e-06	4.28e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—bone cancer	8.48e-06	4.19e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—bone cancer	8.44e-06	4.17e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—bone cancer	8.43e-06	4.16e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—bone cancer	8.43e-06	4.16e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—bone cancer	8.41e-06	4.15e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—bone cancer	8.41e-06	4.15e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—bone cancer	8.33e-06	4.11e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—bone cancer	8.31e-06	4.1e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—bone cancer	7.85e-06	3.88e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—bone cancer	7.08e-06	3.5e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—bone cancer	7.06e-06	3.49e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—bone cancer	7.04e-06	3.48e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—bone cancer	6.99e-06	3.45e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—bone cancer	6.97e-06	3.44e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—bone cancer	6.81e-06	3.36e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—bone cancer	6.81e-06	3.36e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—bone cancer	5.91e-06	2.92e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—bone cancer	5.72e-06	2.82e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—bone cancer	5.72e-06	2.82e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—bone cancer	5.55e-06	2.74e-05	CbGpPWpGaD
